Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlimera Sciences Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2026 | 1 | $0.06 | $0.06 | $0.06 |
| Q3 2026 | 1 | $0.06 | $0.06 | $0.06 |
| Q4 2026 | 1 | $0.12 | $0.12 | $0.12 |
Alimera Sciences Earnings Date And Information
Alimera Sciences last posted its earnings results on Thursday, October 24th, 2024. The company reported $-0.06 earnings per share for the quarter, missing analysts' consensus estimates of $-0.01 by $0.05. The company had revenue of 27.00 M for the quarter and had revenue of 80.75 M for the year. Alimera Sciences has generated $-1 earnings per share over the last year ($-0.79 diluted earnings per share) and currently has a price-to-earnings ratio of -7.03. Alimera Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Alimera Sciences Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/07/2024 | Q2 2024 | N/A | -$0.06 | N/A | $25.74 M | $27.00 M |
| 05/14/2024 | Q1 2024 | -$0.06 | -$0.11 | -0.05 | N/A | $23.01 M |
| 03/08/2024 | Q4 2023 | N/A | -$0.07 | N/A | N/A | $26.31 M |
| 11/01/2023 | Q3 2023 | N/A | -$0.04 | N/A | $22.70 M | $23.36 M |
| 08/11/2023 | Q2 2023 | N/A | -$1.24 | N/A | $20.47 M | $17.54 M |
| 05/15/2023 | Q1 2023 | -$0.58 | -$1.18 | -0.6 | $12.30 M | $13.55 M |
| 03/31/2023 | Q4 2022 | -$0.28 | -$0.54 | -0.26 | $14.63 M | $14.03 M |
| 11/14/2022 | Q3 2022 | -$0.37 | -$0.75 | -0.38 | $15.05 M | $13.60 M |
| 08/05/2022 | Q2 2022 | N/A | -$0.45 | N/A | $13.14 M | $14.60 M |
| 05/12/2022 | Q1 2022 | N/A | -$0.85 | N/A | $12.53 M | $11.90 M |
| 03/23/2022 | Q4 2021 | N/A | -$0.59 | N/A | $13.41 M | $13.96 M |
| 11/05/2021 | Q3 2021 | N/A | -$0.60 | N/A | $12.37 M | $12.15 M |
| 08/16/2021 | Q2 2021 | N/A | $1.03 | N/A | $16.04 M | $21.70 M |
| 05/07/2021 | Q1 2021 | N/A | -$0.63 | N/A | $11.40 M | $11.21 M |
| 03/04/2021 | Q4 2020 | N/A | -$0.18 | N/A | $13.43 M | $13.77 M |
| 11/03/2020 | Q3 2020 | N/A | -$0.12 | N/A | $10.89 M | $12.47 M |
| 08/04/2020 | Q2 2020 | N/A | -$0.51 | N/A | $6.58 M | $10.04 M |
| 05/06/2020 | Q1 2020 | N/A | -$0.24 | N/A | $14.09 M | $14.54 M |
| 03/02/2020 | Q4 2019 | N/A | $0.08 | N/A | $14.99 M | $17.35 M |
| 11/05/2019 | Q3 2019 | N/A | -$0.60 | N/A | $12.79 M | $12.85 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alimera Sciences Earnings: FAQ's
The conference call for Alimera Sciences's latest earnings report can be listened to online.
The conference call transcript for Alimera Sciences's latest earnings report can be read online.
Alimera Sciences (:ALIM) has a recorded annual revenue of $80.75 M.
Alimera Sciences (:ALIM) has a recorded net income of $-20,132,000.Alimera Sciences has generated $-0.79 earnings per share over the last four quarters.
Alimera Sciences (:ALIM) has a price-to-earnings ratio of -7.03 and price/earnings-to-growth ratio is -0.03.